2022 Oncolytic Virotherapies Analytical Tool: 85 Companies Who are Developing 150 Oncolytic Virus Drugs Where 113 are in Active Development in Cancer Across 40 Different Targets
May 11, 2022 07:03 ET
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Oncolytic Virotherapies: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Oncolytic Virotherapies: Analytical Tool is the...
Global Oncolytic Virus Therapies Market Report 2021-2030: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, and Competitive Landscape
April 22, 2021 06:38 ET
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and...
Outlook on the Oncolytic Virus Immunotherapy Global Market to 2026 - Key Drivers and Inhibitors
October 20, 2020 04:08 ET
|
Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026" report has been added to ResearchAndMarkets.com's...